Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xalkori
Xalkori
In warranty program, Pfizer will refund up to $50K for patients who discontinue use of rare disease drug
Fierce Pharma
Wed, 08/10/22 - 12:04 am
Pfizer
Xalkori
warranty
Panzyga
CIPD
Pfizer's Xalkori picks up FDA nod for rare ALK-positive tumors
Fierce Pharma
Fri, 07/15/22 - 11:01 am
Pfizer
FDA
Xalkori
Pfizer’s XALKORI approved by FDA for ALK-positive anaplastic large cell lymphoma in children and young adults
Pharmaceutical Business Review
Fri, 01/15/21 - 10:04 am
Pfizer
Xalkori
FDA
ALK-positive anaplastic large cell lymphoma
ALCL
Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
Fierce Pharma
Wed, 08/5/20 - 11:22 pm
Pfizer
Lorbrena
lung cancer
Xalkori
clinical trials
ASCO: Roche's Alecensa stays on top of Xalkori with long-term survival showing
Fierce Pharma
Wed, 05/13/20 - 10:33 pm
Roche
ASCO 2020
Xalkori
Alecensa
Pfizer
ALK-positive non-small cell lung cancer
Takeda sets sights on first-line lung cancer market with new Alunbrig data
Pharmaforum
Mon, 11/25/19 - 09:49 am
Takeda
Alunbrig
clinical trials
Pfizer
Xalkori
ALK-positive non-small cell lung cancer
Takeda eyes Alunbrig earlier lung cancer use as 2-year data trounce Pfizer’s Xalkori
Fierce Pharma
Sat, 11/23/19 - 04:12 pm
Pfizer
Xalkori
ALK-positive non-small cell lung cancer
Takeda
Alunbrig
Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer
CP Wire
Fri, 10/19/18 - 09:19 am
Takeda
Alunbrig
Xalkori
non-small cell lung cancer
Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer
Fri, 10/19/18 - 09:05 am
Takeda
Alunbrig
Xalkori
non-small cell lung cancer
FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications
CP Wire
Tue, 05/29/18 - 10:37 am
Pfizer
Xalkori
metastatic non-small cell lung cancer
FDA
breakthrough therapies
anaplastic large-cell lymphoma
FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications
Tue, 05/29/18 - 10:14 am
Pfizer
Xalkori
non-small cell lung cancer
anaplastic large-cell lymphoma
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
Fierce Pharma
Tue, 11/7/17 - 10:55 am
Roche
Alecensa
Pfizer
Novartis
lung cancer
Zykadia
Xalkori
ASCO17: Roche's Alecensa bests Xalkori in lung study
BioPharma Dive
Mon, 06/5/17 - 12:11 pm
Roche
Alecensa
Xalkori
ASCO 2017
Pfizer
lung cancer
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Novartis
Zykadia
Pfizer
Xalkori
Roche
Alecensa
non-small cell lung cancer
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:10 am
Roche
Genentech
Pfizer
Xalkori
Alecensa
non-small cell lung cancer
Pfizer Has Strong Track Record since 2010
Market Realist
Fri, 12/16/16 - 11:29 am
Pfizer
drug approvals
Ibrance
Prevnar 13
Inlyta
Xalkori
Xeljanz
Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment
Yahoo/Benzinga
Thu, 09/1/16 - 09:23 am
Pfizer
Europe
Xalkori
non-small cell lung cancer
What Latest Xalkori Approval Means for Pfizer
Bidness, ETC
Mon, 03/14/16 - 10:05 am
Pfizer
Xalkori
FDA
non-small cell lung cancer
Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Yahoo
Tue, 12/8/15 - 11:24 am
Pfizer
FDA
Xalkori
non-small cell lung cancer
Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer
Motley Fool
Sun, 11/22/15 - 10:47 am
chemotherapy
cancer immunotherapies
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
targeted therapies
Pfizer
Xalkori
stem cells
OncoMed
tumor hypoxia
Threshold Pharmaceuticals
Pages
1
2
3
next ›
last »